Part,  Chapter, Paragraph

 1   II,     4.  3    | Executive summary. Washington, DC, U.S. Department of Health
 2   II,     5.  3.  9|        Perspective. Washington DC: AICR.~ ~WHO (2003): Strategies
 3   II,     5.  5.  3|       231.~Brewis M, Poskanzer DC, Rolland C, Miller H (1966):
 4   II,     5.  6.  6|     the World Bank, Washington DC~Magaziner J, Simonsick EM,
 5   II,     5.  7.  7|       K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et
 6   II,     5. 12.  7|     Ioannou G, Doust J, Rockey DC (2003): Terlipressin for
 7   II,     8.  2.  1| Supports (10th Ed) Washington, DC: American Association on
 8   II,     8.  2.  1|        4th Edition, Washington DC, American Psychiatric Association.~
 9  III,    10.  5.  1|    Urban Audit (htt ~ ~Tranter DC (2005): Indoor allergens
10  III,    10.  6.  1|      167(18):1951-7.~ ~Ganster DC, Victor B (1998). The impact
11   IV,    11.  6.  5|        Care Costs? Washington, DC, Government Printing Office.~ ~